Early combination therapy for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 2 diabetes within the past 2 years
- Age between 18 and 70 years old
- Currently taking metformin at a daily dose of at least 1500 mg
- HbA1c (average blood sugar) 8.0% or lower
- No past use of SGLT2i, GLP-1RA, or DPP-4 inhibitor drugs (like empagliflozin, semaglutide, or sitagliptin)
- Body mass index (BMI) between 22 and 40
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests a new medication called bofanglutide in adults with type 2 diabetes who are currently taking metformin. The medication works similarly to a hormone that helps control blood sugar, and the study aims to see if it can help lower blood sugar levels and manage weight better.
This trial tests if adding semaglutide and empagliflozin to your automated insulin delivery system (like a smart pump) can improve blood sugar control for adults with type 1 diabetes. It may help with both glucose levels and weight management.
This study tests two different medicines (empagliflozin or semaglutide) added to your usual insulin to see if they help with blood sugar control and weight loss in people with type 1 diabetes who are overweight or have obesity. It may be a good fit if your diabetes is not well controlled with insulin injections alone.
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
This trial tests if a new form of semaglutide works as well as the approved drug Ozempic for lowering blood sugar. It's for adults with type 2 diabetes who are already taking metformin and need better sugar control.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.